Attachment: 8-K


scl-ex991_27.htm

 

Exhibit 99.1

 

Stepan Reports Record Second Quarter Results and Record First Half Earnings

 

Northfield, Illinois, July 28, 2021 -- Stepan Company (NYSE: SCL) today reported:

 

Second Quarter Highlights

 

 

Reported net income was a record $43.3 million, or $1.85 per diluted share, versus $35.7 million, or $1.54 per diluted share, in the prior year.  Adjusted net income* was a second quarter record $42.2 million, or $1.81 per diluted share, versus $38.3 million, or $1.65 per diluted share, in the prior year.  Total Company sales volume increased 5% versus the prior year.

 

 

 

Surfactant operating income was $45.9 million versus $48.5 million in the prior year. This decrease was largely attributable to higher North American supply chain costs due to inflationary pressures and higher planned maintenance costs.  Global Surfactant sales volume decreased 6% but the associated impact was more than offset by improved margins, product and customer mix.  Consumer product sales volume was negatively impacted by feedstock supply issues following the first quarter 2021 severe weather in Texas, customer inventory rebalancing efforts and lower demand for cleaning products versus the pandemic peak in 2020.  Higher demand for products sold into our institutional cleaning and functional product end markets partially offset the above.        

 

 

 

Polymer operating income was $23.0 million versus $15.5 million in the prior year.  This increase was primarily attributable to a 44% increase in global Polymer sales volume.  Global rigid polyol volume was up 41% versus the prior year largely due to the INVISTA polyester polyol acquisition.  Global rigid polyol volume, excluding the INVISTA acquisition, was up 7% versus the prior year. Higher demand within the phthalic anhydride and specialty polyols businesses also contributed to the sales volume growth.

 

 

 

Specialty Product operating income was $7.0 million versus $3.2 million in the prior year.  This increase was primarily attributable to order timing differences within our food and flavor business and improved margins within our medium chain triglycerides (MCT) product line.

 

 

 

The effect of foreign currency translation positively impacted net sales by 4% and net income by $1.4 million, or $0.06 per diluted share, versus the prior year.

 

 

First Half Highlights

 

 

Reported net income was a record $83.9 million, or $3.59 per diluted share, versus $63.3 million, or $2.72 per diluted share, in the prior year.  Adjusted net income* was a record $84.6 million, or $3.62 per diluted share, versus $62.5 million, or $2.69 per diluted share, in the prior year.  The prior year first half results were negatively impacted by the first quarter 2020 Millsdale, IL plant power outage.  Total Company sales volume was up 6% compared to the first six months of 2020.  A 39% increase in global Polymer sales volume was partially offset by a 3% decrease in global Surfactant sales volume.  

 

1


 

*

Adjusted net income is a non-GAAP measure which excludes deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.

 

 

 

“The Company had a solid first half of 2021 and delivered record year-to-date results.  Both adjusted net income and adjusted EPS were up 35% versus the first half of 2020 which was negatively impact by the Millsdale plant outage,” said F. Quinn Stepan, Jr., Chairman and Chief Executive Officer.  “For the quarter, Surfactant operating income was down 5% largely due to higher North American supply chain costs driven by inflationary pressures and higher planned maintenance.  A 6% decline in global Surfactant sales volume, mostly related to our consumer product business, was more than offset by improved margins, product and customer mix.  Our Polymer operating income was up 48% on the strength of 44% global sales volume growth.  The Polymer growth was driven by both the INVISTA acquisition and organic market growth.  Our Specialty Product business results were up due to higher volume and improved margins.”

 

Financial Summary

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands, except per share data)

2021

 

 

2020

 

 

%

Change

 

 

2021

 

 

2020

 

 

%

Change

 

Net Sales

$

595,511

 

 

$

460,549

 

 

 

29

%

 

$

1,133,251

 

 

$

910,536

 

 

 

24

%

Operating Income

$

56,657

 

 

$

44,623

 

 

 

27

%

 

$

110,571

 

 

$

84,627

 

 

 

31

%

Net Income Attributable to Stepan **

$

43,278

 

 

$

35,707

 

 

 

21

%

 

$

83,889

 

 

$

63,252

 

 

 

33

%

Earnings per Diluted Share

$

1.85

 

 

$

1.54

 

 

 

20

%

 

$

3.59

 

 

$

2.72

 

 

 

32

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income *

$

42,218

 

 

$

38,315

 

 

 

10

%

 

$

84,589

 

 

$

62,473

 

 

 

35

%

Adjusted Earnings per Diluted Share *

$

1.81

 

 

$

1.65

 

 

 

10

%

 

$

3.62

 

 

$

2.69

 

 

 

35

%

 

* See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.

** Net Income Attributable to Stepan = Net Income – Net Income Attributable to Noncontrolling Interests

 

 

Summary of Second Quarter Adjusted Net Income Items

 

Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense and other significant and infrequent or non-recurring items.

 

 

Deferred Compensation:  The current year second quarter reported net income includes $1.1 million of after-tax income versus $1.9 million of after-tax expense in the prior year.  

 

 

Cash-Settled SARs:  These management incentive instruments provide cash to participants equal to the appreciation on the price of specified shares of Company stock over a specified period of time.  Because income or expense is recognized merely on the movement in the price of Company stock it has been excluded, similar to deferred compensation, to arrive at adjusted net income.  The current year second quarter includes $0.1 million of after-tax income versus $0.5 million of after-tax expense in the prior year.

 

2


 

 

Business Restructuring:  The current year second quarter includes $0.1 million of after-tax decommissioning expense related to the Company’s Canadian plant closure versus $0.2 million of after-tax expense in the prior year.

 

Percentage Change in Net Sales

 

Net sales in the second quarter of 2021 increased 29% year-over-year due to higher selling prices, mainly due to improved product and customer mix and the pass-through of higher raw material costs, a 5% increase in global sales volume and the favorable impact of foreign currency translation.  The increase in sales volume was predominantly due to Polymer sales growth of 44%.  

 

 

 

Three Months Ended

June 30, 2021

 

 

Six Months Ended

June 30, 2021

 

Volume

 

 

5

%

 

 

6

%

Selling Price & Mix

 

 

20

%

 

 

16

%

Foreign Translation

 

 

4

%

 

 

2

%

Total

 

 

29

%

 

 

24

%

 

Segment Results

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2021

 

 

2020

 

 

%

Change

 

 

2021

 

 

2020

 

 

%

Change

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Surfactants

 

$

384,002

 

 

$

332,335

 

 

 

16

%

 

$

754,938

 

 

$

659,406

 

 

 

14

%

Polymers

 

$

190,538

 

 

$

112,409

 

 

 

70

%

 

$

340,923

 

 

$

218,900

 

 

 

56

%

Specialty Products

 

$

20,971

 

 

$

15,805

 

 

 

33

%

 

$

37,390

 

 

$

32,230

 

 

 

16

%

Total Net Sales

 

$

595,511

 

 

$

460,549

 

 

 

29

%

 

$

1,133,251

 

 

$

910,536

 

 

 

24

%

 

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2021

 

 

2020

 

 

%

Change

 

 

2021

 

 

2020

 

 

%

Change

 

Operating Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Surfactants

 

$

45,896

 

 

$

48,503

 

 

 

(5

)%

 

$

99,106

 

 

$

84,659

 

 

 

17

%

Polymers

 

$

23,025

 

 

$

15,527

 

 

 

48

%

 

$

40,976

 

 

$

23,043

 

 

 

78

%

Specialty Products

 

$

6,977

 

 

$

3,226

 

 

 

116

%

 

$

9,610

 

 

$

7,210

 

 

 

33

%

Total Segment Operating Income

 

$

75,898

 

 

$

67,256

 

 

 

13

%

 

$

149,692

 

 

$

114,912

 

 

 

30

%

Corporate Expenses

 

$

(19,241

)

 

$

(22,633

)

 

 

(15

)%

 

$

(39,121

)

 

$

(30,285

)

 

 

29

%

Consolidated Operating Income

 

$

56,657

 

 

$

44,623

 

 

 

27

%

 

$

110,571

 

 

$

84,627

 

 

 

31

%

 

 

Total segment operating income increased $8.6 million, or 13%, versus the prior year quarter.  Total segment operating income in the first half of 2021 increased $34.8 million, or 30%, versus the prior year.

 

Surfactant net sales were $384.0 million for the quarter, a 16% increase versus the prior year.  Selling prices were up 17% primarily due to improved product and customer mix as well as the pass-through of higher raw material costs.  The effect of foreign currency translation positively impacted net sales by 5%.  Sales volume in the

3


second quarter of 2021 decreased 6% year-over-year.  Most of this decrease reflects lower sales volume into the North American consumer product end markets as a result of feedstock supply issues, customer inventory rebalancing efforts and lower demand for consumer cleaning, disinfection and personal wash products versus the pandemic peak in 2020. Higher demand for products sold into our institutional cleaning and functional product end markets partially offset the above.  Surfactant operating income for the quarter decreased $2.6 million, or 5%, versus the prior year quarter primarily due higher North American supply chain costs related to inflationary pressures and planned higher maintenance costs.  Improved margins, product and customer mix partially offset the impact of the 6% decline in global sales volume and higher supply chain costs.  Latin American operating results benefited from a $2.1 million VAT tax recovery in the current year quarter.

 

Polymer net sales were $190.5 million for the quarter, a 70% increase versus the prior year.  Sales volume increased 44% in the quarter primarily due to 41% growth in rigid polyol demand.  Global rigid polyol volume, excluding the INVISTA acquisition, was up 7% versus the prior year.  Higher demand within the phthalic anhydride and specialty polyols businesses also contributed to the sales volume growth.  Selling prices increased 21% and the translation impact of a weaker U.S. dollar positively increased net sales by 5%.  Polymer operating income increased $7.5 million, or 48%, primarily due to the strong sales volume growth.    

 

 

Specialty Product net sales were $21.0 million for the quarter, up 33% versus the prior year.  Sales volume was up 17% between quarters and operating income increased $3.8 million, or 116%.  The operating income increase was primarily attributable to order timing differences within our food and flavor business and improved margins within our medium chain triglycerides product line.

 

 

Corporate Expenses

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2021

 

 

2020

 

 

%

Change

 

 

2021

 

 

2020

 

 

%

Change

 

Total Corporate Expenses

 

$

19,241

 

 

$

22,633

 

 

 

(15

)%

 

$

39,121

 

 

$

30,285

 

 

 

29

%

Less:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred Compensation

 

$

(958

)

 

$

(6,464

)

 

 

(85

)%

 

$

(3,652

)

 

$

859

 

 

NM

 

     Business Restructuring

 

$

(114

)

 

$

(225

)

 

 

(49

)%

 

$

(195

)

 

$

(582

)

 

 

(66

)%

Adjusted Corporate Expense

 

$

18,169

 

 

$

15,944

 

 

 

14

%

 

$

35,274

 

 

$

30,562

 

 

 

15

%

 

* See Table III for a discussion of deferred compensation plan accounting.

    

Corporate expenses, excluding deferred compensation and business restructuring costs, increased $2.2 million, or 14%, versus the prior year quarter.  The quarterly increase was primarily due to the non-recurrence of a sales and use tax refund received in the second quarter of 2020 combined with higher acquisition-related expenses, insurance premiums and cloud application costs in 2021.    

 

Income Taxes

 

The Company’s effective tax rate was 24.4% for the first half of 2021 versus 23.9% for the first half of 2020.  This year-over-year increase was primarily attributable to a less favorable

4


geographical mix of income in the first half of 2021 versus 2020, partially offset by higher tax benefits derived from stock-based compensation awards exercised or distributed in the first half of 2021 versus 2020.      

 

Shareholder Return

 

The Company paid $6.9 million of dividends to shareholders and repurchased $9.9 million of Company stock in the second quarter of 2021.  During the first six months of 2021 the Company paid $13.7 million of dividends and repurchased $10.9 million of Company stock.  The Company has 93,829 shares remaining under its Board of Directors’ share repurchase authorization.  The Company has increased its dividend on the Company’s common stock for 53 consecutive years.  

 

Selected Balance Sheet Information

 

The Company’s net debt level increased $14.1 million versus the first quarter of 2021 while the net debt ratio increased from 9% to 10%.  The increase in net debt reflects a $23.6 million decrease in cash and a $9.5 million decrease in debt.  The decrease in cash was driven by scheduled debt repayments in June 2021 and higher working capital requirements.      

 

($ in millions)

6/30/21

 

 

3/31/21

 

 

12/31/20

 

Net Debt

 

 

 

 

 

 

 

 

 

 

 

Total Debt

$

238.9

 

 

$

248.4

 

 

$

198.7

 

Cash

 

127.1

 

 

 

150.7

 

 

 

349.9

 

Net Debt

$

111.8

 

 

$

97.7

 

 

$

(151.2

)

Equity

 

1,048.8

 

 

 

1,002.3

 

 

 

986.7

 

Net Debt + Equity

$

1,160.6

 

 

$

1,100.0

 

 

$

835.5

 

Net Debt / (Net Debt + Equity)

 

10

%

 

 

9

%

 

 

-18

%

 

The major working capital components were:

 

($ in millions)

6/30/21

 

 

3/31/21

 

 

12/31/20

 

Net Receivables

$

391.7

 

 

$

380.6

 

 

$

301.3

 

Inventories

 

266.1

 

 

 

235.1

 

 

 

218.8

 

Accounts Payable

 

(286.9

)

 

 

(264.2

)

 

 

(236.8

)

Total

$

370.9

 

 

$

351.5

 

 

$

283.3

 

 

Capital spending was $37.3 million during the quarter and $74.9 million during the first half of 2021.  This compares to $21.5 million and $54.7 million, respectively, in the prior year.  For the full year, capital expenditures are expected to be in the range of $150 million to $170 million.  

 

Outlook

 

“The Company delivered record earnings in the first half of 2021,” said F. Quinn Stepan, Jr., Chairman and Chief Executive Officer.  “Looking forward, we believe our Surfactant volumes in the North American consumer product end markets will be challenged versus peak pandemic levels in 2020.  While we believe institutional cleaning volume will continue to grow versus prior year, we do not believe it will compensate for lower consumer consumption of cleaning, disinfection and personal wash products.  We anticipate that demand for surfactants within the agricultural and oilfield markets will benefit from higher

5


agricultural and commodity prices and improve versus 2020.  Global demand for rigid polyols continues to recover from pandemic-related delays and cancellations of re-roofing and new construction projects.  This recovery, combined with our first quarter 2021 acquisition of INVISTA’s aromatic polyester polyol business, should position our Polymer business to deliver growth versus prior year.  We believe the long-term prospects for rigid polyols remain attractive as energy conservation efforts and more stringent building codes are expected to continue.  We anticipate our Specialty Product business results will improve slightly year-over-year.  Despite continued raw material price increases, supply chain inflationary pressures and planned second half maintenance expenses, we remain cautiously optimistic about the remainder of the year.      

 

Conference Call

 

Stepan Company will host a conference call to discuss the second quarter results at 10:00 a.m. ET (9:00 a.m. CT) on July 28, 2021. The call can be accessed by phone and webcast. Telephone access will be available by dialing +1 (800) 584-2088, and the webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

 

Supporting Slides

 

Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.

 

Corporate Profile

 

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

 

Headquartered in Northfield, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

 

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

 

More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com

 

Contact: Luis E. Rojo 847-446-7500

 

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or

6


prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

 

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

 

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7


 

Table I

STEPAN COMPANY

For the Three and Six Months Ended June 30, 2021 and 2020

(Unaudited – ‘000’s Omitted)

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net Sales

 

$

595,511

 

 

$

460,549

 

 

$

1,133,251

 

 

$

910,536

 

Cost of Sales

 

 

483,830

 

 

 

362,054

 

 

 

912,590

 

 

 

732,772

 

Gross Profit

 

 

111,681

 

 

 

98,495

 

 

 

220,661

 

 

 

177,764

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 

14,990

 

 

 

12,921

 

 

 

29,494

 

 

 

26,453

 

Administrative

 

 

23,974

 

 

 

20,731

 

 

 

46,612

 

 

 

39,603

 

Research, Development and Technical Services

 

 

14,988

 

 

 

13,531

 

 

 

30,137

 

 

 

27,358

 

Deferred Compensation (Income) Expense

 

 

958

 

 

 

6,464

 

 

 

3,652

 

 

 

(859

)

 

 

 

54,910

 

 

 

53,647

 

 

 

109,895

 

 

 

92,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Business Restructuring

 

 

114

 

 

 

225

 

 

 

195

 

 

 

582

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

 

56,657

 

 

 

44,623

 

 

 

110,571

 

 

 

84,627

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest, Net

 

 

(1,567

)

 

 

(1,259

)

 

 

(3,091

)

 

 

(2,489

)

Other, Net

 

 

2,758

 

 

 

4,437

 

 

 

3,504

 

 

 

1,175

 

 

 

 

1,191

 

 

 

3,178

 

 

 

413

 

 

 

(1,314

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Before Income Taxes

 

 

57,848

 

 

 

47,801

 

 

 

110,984

 

 

 

83,313

 

Provision for Income Taxes

 

 

14,545

 

 

 

11,958

 

 

 

27,070

 

 

 

19,931

 

Net Income

 

 

43,303

 

 

 

35,843

 

 

 

83,914

 

 

 

63,382

 

Net Income Attributable to Noncontrolling Interests

 

 

(25

)

 

 

(136

)

 

 

(25

)

 

 

(130

)

Net Income Attributable to Stepan Company

 

$

43,278

 

 

$

35,707

 

 

$

83,889

 

 

$

63,252

 

Net Income Per Common Share Attributable to Stepan Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.89

 

 

$

1.56

 

 

$

3.65

 

 

$

2.75

 

Diluted

 

$

1.85

 

 

$

1.54

 

 

$

3.59

 

 

$

2.72

 

Shares Used to Compute Net Income Per Common

Share Attributable to Stepan Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

22,952

 

 

 

22,923

 

 

 

22,963

 

 

 

22,973

 

Diluted

 

 

23,345

 

 

 

23,184

 

 

 

23,338

 

 

 

23,235

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8


 

 

 

Table II

 

Reconciliations of Non-GAAP Net Income and Earnings per Diluted Share *

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands, except per share amounts)

 

2021

 

 

EPS

 

 

2020

 

 

EPS

 

 

2021

 

 

EPS

 

 

2020

 

 

EPS

 

Net Income Reported

 

$

43,278

 

 

$

1.85

 

 

$

35,707

 

 

$

1.54

 

 

$

83,889

 

 

$

3.59

 

 

$

63,252

 

 

$

2.72

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred Compensation (Income) Expense

 

$

(1,050

)

 

$

(0.04

)

 

$

1,938

 

 

$

0.08

 

 

$

451

 

 

$

0.02

 

 

$

(920

)

 

$

(0.04

)

Business Restructuring Expense

 

$

85

 

 

$

0.00

 

 

$

168

 

 

$

0.01

 

 

$

146

 

 

$

0.01

 

 

$

431

 

 

$

0.02

 

Cash-Settled SARs (Income) Expense

 

$

(95

)

 

$

(0.00

)

 

$

502

 

 

$

0.02

 

 

$

103

 

 

$

0.00

 

 

$

(290

)

 

$

(0.01

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income

 

$

42,218

 

 

$

1.81

 

 

$

38,315

 

 

$

1.65

 

 

$

84,589

 

 

$

3.62

 

 

$

62,473

 

 

$

2.69

 

 

* All amounts in this table are presented after-tax

 

The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items.  Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators.  These measures should be considered in addition to, and neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.

 

Reconciliation of Pre-Tax to After-Tax Adjustments

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands, except per share amounts)

 

2021

 

 

EPS

 

 

2020

 

 

EPS

 

 

2021

 

 

EPS

 

 

2020

 

 

EPS

 

Pre-Tax Adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred Compensation (Income) Expense

 

$

(1,381

)

 

 

 

 

 

$

2,550

 

 

 

 

 

 

$

594

 

 

 

 

 

 

$

(1,210

)

 

 

 

 

Business Restructuring Expense

 

$

114

 

 

 

 

 

 

$

225

 

 

 

 

 

 

$

195

 

 

 

 

 

 

$

582

 

 

 

 

 

Cash-Settled SARs (Income) Expense

 

$

(125

)

 

 

 

 

 

$

661

 

 

 

 

 

 

$

136

 

 

 

 

 

 

$

(381

)

 

 

 

 

   Total Pre-Tax Adjustments

 

$

(1,392

)

 

 

 

 

 

$

3,436

 

 

 

 

 

 

$

925

 

 

 

 

 

 

$

(1,009

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative Tax Effect on Adjustments

 

$

332

 

 

 

 

 

 

$

(828

)

 

 

 

 

 

$

(225

)

 

 

 

 

 

$

230

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

After-Tax Adjustments

 

$

(1,060

)

 

$

(0.04

)

 

$

2,608

 

 

$

0.11

 

 

$

700

 

 

$

0.03

 

 

$

(779

)

 

$

(0.03

)

 

 

 

 

 

9


 

Table III

 

 

Deferred Compensation Plans

 

 

The full effect of deferred compensation plans on quarterly pre-tax income was $1.4 million of income versus $2.6 million of expense in the prior year. The year to date impact was $0.6 million of expense versus $1.2 million of income in the prior year. The accounting for deferred compensation plans results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The quarter end market prices of Company common stock were as follows:

 

 

 

2021

 

 

2020

 

 

 

12/31

 

9/30

 

6/30

 

 

3/31

 

 

12/31

 

 

9/30

 

 

6/30

 

 

3/31

 

Stepan Company

 

N/A

 

N/A

 

$

120.27

 

 

$

127.11

 

 

$

119.32

 

 

$

109.00

 

 

$

97.10

 

 

$

88.46

 

 

 

The deferred compensation income statement impact is summarized below:

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Deferred Compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income (Expense)

 

$

(958

)

 

$

(6,464

)

 

$

(3,652

)

 

$

859

 

Other, net – Mutual Fund Gain

 

 

2,339

 

 

 

3,914

 

 

 

3,058

 

 

 

351

 

Total Pretax

 

$

1,381

 

 

$

(2,550

)

 

$

(594

)

 

$

1,210

 

Total After Tax

 

$

1,050

 

 

$

(1,938

)

 

$

(451

)

 

$

920

 

 

 

 

 


10


 

 

Table IV

 

 

Effects of Foreign Currency Translation

 

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results).  Below is a table that presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the three and six month periods ending June 30, 2021 as compared to 2020:

 

($ in millions)

 

Three Months Ended

June 30

 

 

Increase

 

 

Increase

Due to Foreign

Currency

Translation

 

 

Six Months Ended

June 30

 

 

Increase

 

 

Increase

Due to Foreign

Currency

Translation

 

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

Net Sales

 

$

595.5

 

 

$

460.5

 

 

$

135.0

 

 

$

20.3

 

 

$

1,133.3

 

 

$

910.5

 

 

$

222.8

 

 

$

24.6

 

Gross Profit

 

 

111.7

 

 

 

98.5

 

 

 

13.2

 

 

 

2.7

 

 

 

220.7

 

 

 

177.8

 

 

 

42.9

 

 

 

2.9

 

Operating Income

 

 

56.7

 

 

 

44.6

 

 

 

12.1

 

 

 

1.7

 

 

 

110.6

 

 

 

84.6

 

 

 

26.0

 

 

 

1.6

 

Pretax Income

 

 

57.8

 

 

 

47.8

 

 

 

10.0

 

 

 

1.9

 

 

 

111.0

 

 

 

83.3

 

 

 

27.7

 

 

 

2.0

 

 

 


11


 

 

Table V

 

 

Stepan Company

Consolidated Balance Sheets

June 30, 2021 and December 31, 2020

 

 

 

June 30, 2021

 

 

December 31, 2020

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

$

815,855

 

 

$

905,651

 

Property, Plant & Equipment, Net

 

 

764,784

 

 

 

682,667

 

Other Assets

 

 

306,666

 

 

 

164,018

 

Total Assets

 

$

1,887,305

 

 

$

1,752,336

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities

 

$

464,501

 

 

$

416,554

 

Deferred Income Taxes

 

 

9,995

 

 

 

20,745

 

Long-term Debt

 

 

196,529

 

 

 

160,812

 

Other Non-current Liabilities

 

 

165,764

 

 

 

165,860

 

Total Stepan Company Stockholders’ Equity

 

 

1,048,801

 

 

 

986,693

 

Noncontrolling Interest

 

 

1,715

 

 

 

1,672

 

Total Liabilities and Stockholders’ Equity

 

$

1,887,305

 

 

$

1,752,336

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12


scl-ex992_26.htm

Exhibit 99.2

 

Stepan Declares Quarterly Dividend

 

Northfield, Illinois, July 28, 2021 -- Stepan Company (NYSE:SCL) today reported:

 

On July 27, 2021, the Board of Directors of Stepan Company declared a quarterly cash dividend on the Company’s common stock of $0.305 per share.  The dividend is payable on September 15, 2021, to common stockholders of record on August 31, 2021. The Company increased its quarterly cash dividend in the fourth quarter of 2020 by $0.03 per share, marking the 53rd consecutive year that the Company has increased its cash dividend to stockholders.  

 

Corporate Profile

 

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

 

Headquartered in Northfield, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

 

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

 

More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com

 

Contact: Luis E. Rojo 847-446-7500

 

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

 

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-


looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

 

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

 


scl-20210728.xsd
Attachment: XBRL TAXONOMY EXTENSION SCHEMA


scl-20210728_lab.xml
Attachment: XBRL TAXONOMY EXTENSION LABEL LINKBASE


scl-20210728_pre.xml
Attachment: XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE